[Thromboembolic risk in inflammatory bowel disease].
Patients with inflammatory bowel disease have a roughly doubled risk of venous thromboembolic events (and of venous thromboembolic relapse), especially during flare-ups. Antithrombotic prophylaxis should be considered during flare-ups (even when rectal bleeding is present) and should probably been continued after hospital discharge. The treatment of established venous thrombosis and pulmonary embolism should follows the general rules.